识别基洛伊德的潜在药物标:孟德尔的随机化研究
Yinmin Wang1, Xiuxia Wang1, Zhaoqi Yuan1
1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
The Journal of investigative dermatology
|May 26, 2024
概括
鉴定类细胞的新药标是非常重要的. 这项研究使用门德尔的随机化方法发现了七个潜在的蛋白质标,其中神经胺 (NTM) 特别有望用于 keloid 治疗.
科学领域:
- 皮肤病学 皮肤病学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 状体是一种具有挑战性的皮肤纤维化疾病,具有高复发率和治疗副作用.
- 有效的 keloid 治疗需要识别新的药物点.
研究的目的:
- 通过强大的遗传方法识别和验证潜在的蛋白质药物点,用于 keloid 治疗.
- 研究质组织中候选蛋白质的相关性和表达模式.
主要方法:
- 使用蛋白质和 keloid GWAS 数据进行了两样本的门德尔随机化分析.
- 基于总结数据的门德尔随机化和同地化分析被用来评估因果关系,并区分因果关系与性.
- 用单细胞RNA测序,Western Blot和免疫光染色来验证候选目标.
主要成果:
- 七种蛋白质被确定为潜在的 keloid 药物点.
- 刺相互作用蛋白,神经胺 (NTM),KLKB1和CRIPTO显示与 keloids 的正相关性.
- PLXNC1,SCG3和PDGFD显示出负相关性;NTM,PLXNC1和PDGFD在纤维细胞中表达很高,NTM在 keloids 中显著增加.
结论:
- 神经素 (NTM),PLXNC1和PDGFD是有前途的药物点,因为它们的纤维细胞表达和与 keloid 现型的相关性.
- 特别是NTM显示了基洛因体的显著上调,这表明它具有很高的治疗潜力.
- 这些已识别的蛋白质为开发更有效的 keloid 治疗提供了新的途径.
相关概念视频
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K